CellaVision AB: Interim Report January - September 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Strong sales and substantial improvement in earnings in the third quarter

January 1 - September 30, 2013

* Net sales were SEK 115.0 million (119.1).
* Operating profit was SEK 9.6 million (13.9).
* Result before tax was SEK 8.4 million (12.4).
* Earnings per share were SEK 0.26 (0.40).
* Cash and cash equivalents were SEK 42.6 million (52.6) at the end of the period.

Help employers find you! Check out all the jobs and post your resume.

Back to news